Rankings
▼
Calendar
PASG Q2 2019 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena
PASG
Passage Bio, Inc.
$28M
Q2 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$8M
Net Income
-$13M
EPS (Diluted)
$-11.20
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$92,000
← FY 2019
All Quarters
Q3 2019 →
